American Diabetes Association
Browse

Subtypes of Gestational Diabetes Mellitus Are Differentially Associated with Newborn and Childhood Metabolic Outcomes

figure
posted on 2025-01-09, 21:12 authored by Meredith E. Osmulski, Yuanzhi Yu, Alan Kuang, Jami L. Josefson, Marie-France Hivert, Denise M. Scholtens, William L. Lowe, Jr

OBJECTIVE Subtypes of gestational diabetes (GDM) based on insulin sensitivity and secretion have been described. We addressed the hypothesis that GDM subtypes are differentially associated with newborn and child anthropometric and glycemic outcomes. RESEARCH DESIGN AND METHODS Newborn and child (age 11-14 yrs) outcomes were examined in 7970 and 4160 mother-offspring dyads, respectively, who participated in the Hyperglycemia and Adverse Pregnancy Outcome Study (HAPO) and Follow-Up Study. GDM was classified as insulin-deficient GDM (insulin secretion <25th percentile with preserved insulin sensitivity), insulin-resistant GDM (insulin sensitivity <25th percentile with preserved insulin secretion) or mixed-defect GDM (both <25th percentile). Regression models for newborn and child outcomes included adjustment for field center, maternal BMI and other pregnancy covariates. Child models also included adjustment for child age, sex, and family history of diabetes. RESULTS Compared to mothers with normal glucose tolerance, all three GDM subtypes were associated with birthweight and sum of skinfolds >90th percentile. Insulin-resistant and mixed-defect GDM were associated with higher risk of cord C-peptide levels >90th percentile; insulin-resistant GDM was associated with higher risk of neonatal hypoglycemia. Insulin-resistant GDM was associated with higher risk of childhood obesity (OR=1.53, CI=1.127-2.08). Insulin-resistant and mixed-defect GDM were associated with higher risk of child impaired glucose tolerance (OR=2.21, CI=1.50-3.25 and OR=3.01, 1.47-6.19, respectively). CONCLUSIONS GDM subtypes are differentially associated with newborn and childhood outcomes. Better characterizing individuals with GDM could help identify at-risk offspring to offer targeted, preventative interventions early in life.

Funding

This study was funded by NIH grants 1U01DK094830, DK117491, HD34242, and HD34243. The study funder was not involved in the design of the study, the collection, analysis and interpretation of data or writing the report, and did not impose any restrictions regarding publication of the report.

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC